Efficacy and Safety of the Soricle for Subjective Tinnitus Relief
Key facts
- Who runs it
- Neurive Co.,Ltd.
- Where
- South Korea1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 36 people enrolled
- Started
- 10 Mar 2025
- Ended
- 8 Sept 2025
- Type of study
- Interventional, 3 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- Sham Device
- tVNS Device
- tVNS + Sound Stimulation Device
- Record updated
- 23 April 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Adults aged 18 years or older
- Patients with subjective tinnitus
- Able to understand and provide informed consent
- Willing to comply with study procedures
Who cannot take part
- History of neurological or psychiatric disorders that may affect study outcomes
- Any condition that, in the investigator's judgment, may interfere with study participation
- Objective tinnitus
- Severe hearing loss requiring immediate treatment
- Use of other tinnitus treatments during the study period
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study was conducted to evaluate the efficacy and safety of Soricle, a medical device combining transcutaneous vagus nerve stimulation and sound stimulation, in patients with subjective tinnitus.
Read full original descriptionShow less
Participants were randomly assigned to either the active treatment group or a sham control group in a double-blind manner. The device was used daily for 8 weeks.
The primary objective was to assess the improvement in tinnitus symptoms, and safety was evaluated throughout the study period.
The 3 groups in the trial
- Sham ComparatorSham treatment, for comparison
Participants received a sham device identical in appearance to the active device but without delivering therapeutic stimulation.
Treatment: Sham Device
- tVNS StimulationTreatment being tested
Participants received transcutaneous vagus nerve stimulation (tVNS) using the investigational device.
Treatment: tVNS Device
- tVNS + Sound StimulationTreatment being tested
Participants received combined transcutaneous vagus nerve stimulation (tVNS) and sound stimulation using the investigational device.
Treatment: tVNS + Sound Stimulation Device
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Efficacy and Safety of the Soricle, a Class III Combination Device of Vagus Nerve Stimulation and Sound Stimulation, for Subjective Tinnitus Relief: A Prospective, Single-Center, Randomized, Double-Blind, Sham-Controlled, Exploratory Clinical Trial
- Record updated
- 23 April 2026